U.S. markets close in 3 hours 35 minutes

Checkpoint Therapeutics, Inc. (CKPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.7699+0.1199 (+4.52%)
As of 12:23PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.6500
Bid2.7600 x 1200
Ask2.7700 x 1000
Day's Range2.6900 - 2.7800
52 Week Range1.9000 - 5.3760
Avg. Volume1,502,533
Market Cap219.331M
Beta (5Y Monthly)1.66
PE Ratio (TTM)N/A
EPS (TTM)-0.4330
Earnings DateAug 03, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference

    Checkpoint Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference

    NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in the Ladenburg Thalmann 2021 Healthcare Conference, taking place July 13-14, 2021. The company will present a corporate update on Wednesday, July 14, 2021, at 11:30 a.m. ET and will also participate in one-on-one meetings during the confe

  • Why Checkpoint Therapeutics Skyrocketed Today
    Motley Fool

    Why Checkpoint Therapeutics Skyrocketed Today

    One very big stock market winner on Wednesday was Checkpoint Therapeutics (NASDAQ: CKPT). B. Riley Securities prognosticator Justin Walsh is bullish on Checkpoint. Walsh is so hot on Checkpoint's prospects, he's initiating his coverage with a buy rating and an $18 per-share price target -- which was nearly seven times Tuesday's closing stock price.

  • TheStreet.com

    5 Top Stock Gainers for Wednesday: SPI Energy, Checkpoint Therapeutics

    SPI Energy, Checkpoint Therapeutics, Aethlon Medical, Clovis Oncology and World Wrestling Entertainment are five top gainers for Wednesday.